Valacyclovir for Herpes Simplex Virus Infection: Long‐Term Safety and Sustained Efficacy after 20 Years’ Experience with Acyclovir
Open Access
- 15 October 2002
- journal article
- review article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 186 (s1) , S40-S46
- https://doi.org/10.1086/342966
Abstract
An extensive clinical trial program combined with 5 years’ postmarketing experience with valacyclovir provides evidence of favorable safety and efficKeywords
This publication has 35 references indexed in Scilit:
- An Investigation of the Steady‐State Pharmacokinetics of Oral Valacyclovir in Immunocompromised ChildrenThe Journal of Infectious Diseases, 2002
- Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: Can intravenous acyclovir be substituted by oral valacyclovir?Medical and Pediatric Oncology, 2002
- Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpesPublished by Wolters Kluwer Health ,1999
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Preclinical Development of Antiviral DrugsClinical Infectious Diseases, 1996
- Nine year effectiveness of continuous suppressive therapy with acyclovir (ACV) in patients with recurrent genital herpes (RGH)Journal of the European Academy of Dermatology and Venereology, 1995
- Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovirJournal of Medical Virology, 1993
- Acyclovir in late pregnancy to prevent neonatal herpes simplexThe Lancet, 1990
- Use of acyclovir to treat chickenpox in pregnancyBMJ, 1988
- Acyclovir and pregnancy.BMJ, 1987